NightstaRx Company Culture
NightstaRx Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterNightstaRx Company Information
NightstaRx Company Overview
Developer of a gene therapy designed to maintain and restore sight in patients with inherited retinal dystrophies. The company's gene therapy is potentially a sight restoring therapy for a rare degenerative disease causing blindness known as Choroideremia, enabling patients to get treated for several rare conditions caused by mutations in a single gene.
NightstaRx was founded in 2014 and its current CEO is David Fellows. Since its inception 12 years ago, NightstaRx has grown to 12 employees.
| Headquarter | Wellcome Gibbs Building, London NW1 2BE United Kingdom |
|---|---|
| Website | www.nightstarx.com |
| Founding Date | 2014 |
| Company Status | Private |
NightstaRx Competitors
NightstaRx competitors include Illumina and Ultragenyx Pharmaceutical. See below how NightstaRx compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
NightstaRx Careers
NightstaRx Jobs
No Recent Jobs found for NightstaRx on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let NightstaRx Know You Want To Work There
Frequently Asked Questions regarding NightstaRx
What is NightstaRx address?
NightstaRx location is at Wellcome Gibbs Building, London
How many employees work in NightstaRx?
NightstaRx has 12 employees
Who are NightstaRx competitors?
NightstaRx main competitors are Illumina, Ultragenyx Pharmaceutical
Who is NightstaRx leadership?
are part of NightstaRx leadership, David Fellows is the CEO
×